Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2026-02-21 @ 1:35 AM
Study NCT ID:
NCT00107250
Status:
COMPLETED
Last Update Posted:
2023-08-04
First Post:
2005-04-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)
Sponsor:
NCIC Clinical Trials Group
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
I171
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None